Biocorrx (OTCMKTS:BICX) Announces Earnings Results

Biocorrx (OTCMKTS:BICX) posted its quarterly earnings data on Friday. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03, Zacks reports. The firm had revenue of $0.22 million for the quarter, compared to the consensus estimate of $0.22 million.

Biocorrx Stock Up 20.9%

BICX stock opened at $0.49 on Friday. Biocorrx has a twelve month low of $0.20 and a twelve month high of $1.28. The stock has a market capitalization of $14.36 million, a price-to-earnings ratio of -2.60 and a beta of 0.17. The firm’s fifty day simple moving average is $0.37 and its two-hundred day simple moving average is $0.36.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.